Injection Drug Use Bridge to Health Program Team
Megan Rose Curtis, MD
Assistant Professor of Medicine
- Email: curtismegan@wustl.edu
Dr. Curtis specializes in clinical infectious diseases, with a particular focus on diseases impacting pregnant people living with substance use disorders, such as HIV, hepatitis C, and syphilis.
Michael Durkin, MD, MPH
Associate Professor of Medicine
- Phone: 314-454-8354
- Fax: 314-454-5392
- Email: mdurkin@wustl.edu
Dr. Durkin uses administrative data to identify opportunities to improve antibiotic prescribing in outpatient settings, with a focus on outpatient and community settings; harnesses survey and qualitative research methods to identify potential solutions based on input from frontline providers; and designs, pilot tests, and disseminates antibiotic stewardship interventions using dissemination & implementation science and informatics technology.
Jessica Elrod-Gallegos, MSW, LCSW
Clinical Case Manager
- Phone: 314-584-0425
- Email: gallegos@wustl.edu
Laura Marks, MD, PhD
Assistant Professor of Medicine
Dr. Marks is a core faculty member of the ID Fellowship Training Program, serving as Director of Fellow Basic/Translational research, infectious diseases and substance use. She specializes in clinical infectious diseases with a special focus on infectious complications in people who inject drugs, such as infective endocarditis and Hepatitis B & C virus infections. Other core research interests include infections in pregnant women.
Madeline McCrary, MD
Assistant Professor of Medicine (Sept 2023)
- Email: mccrary@wustl.edu
Dr. McCrary specializes in clinical infectious diseases and addiction medicine with a special focus on the infectious complications of substance use, such as Hepatitis C and Serratia endocarditis, and related quality improvement initiatives.
Rachel M. Presti, MD, PhD
Professor, Infectious Diseases | Medical Director of the Infectious Disease Clinical Research Unit (IDCRU)
- Phone: 314-454-8215
- Fax: 314-454-5392
- Email: prestir@wustl.edu
Dr. Presti specializes in clinical and translational research in infectious disease, with a special focus on HIV, SARS-CoV-2 and other viral infections.